(Q45115470)

9 December 2017

title

Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy (English)

1 reference

9 December 2017

4

Michael Boeckh

1 reference

9 December 2017

3

Lawrence Corey

1 reference

9 December 2017

2

Katherine A Guthrie

1 reference

9 December 2017

1

W Garrett Nichols

1 reference

9 December 2017

language of work or name

English

0 references

publication date

11 October 2004

1 reference

Clinical Infectious Diseases

9 December 2017

published in

1 reference

9 December 2017

volume

39

1 reference

9 December 2017

issue

9

1 reference

9 December 2017

page(s)

1300-1306

1 reference

Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience

9 December 2017

cites work

1 reference

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome

21 January 2018

1 reference

Mortality associated with influenza and respiratory syncytial virus in the United States

21 January 2018

1 reference

Viral infections in immunocompromised patients: what's new with respiratory viruses?

21 January 2018

1 reference

Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience

21 January 2018

1 reference

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation.

21 January 2018

1 reference

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

21 January 2018

1 reference

Low mortality rates related to respiratory virus infections after bone marrow transplantation

21 January 2018

1 reference

The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation

21 January 2018

1 reference

Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient

21 January 2018

1 reference

Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/425004

1 reference

9 December 2017

1 reference